Laia Simo-Riudalbas

Laia Simo-Riudalbas

UNVERIFIED PROFILE

Are you Laia Simo-Riudalbas?   Register this Author

Register author
Laia Simo-Riudalbas

Laia Simo-Riudalbas

Publications by authors named "Laia Simo-Riudalbas"

Are you Laia Simo-Riudalbas?   Register this Author

9Publications

185Reads

23Profile Views

Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer.

Oncotarget 2017 Aug 29;8(31):51621-51629. Epub 2017 May 29.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584274PMC
August 2017

Barcelona Conference on Epigenetics and Cancer: 50 years of histone acetylation.

Epigenetics 2015 ;10(5):446-51

a Cancer Epigenetics Group; Cancer Epigenetics and Biology Program (PEBC); Bellvitge Biomedical Research Institute (IDIBELL) ; Barcelona , Catalonia , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15592294.2015.1039222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622646PMC
January 2016

KAT6B Is a Tumor Suppressor Histone H3 Lysine 23 Acetyltransferase Undergoing Genomic Loss in Small Cell Lung Cancer.

Cancer Res 2015 Sep 24;75(18):3936-45. Epub 2015 Jul 24.

Cancer Epigenetics Group, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain. Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain. Institucio Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-3702DOI Listing
September 2015

Targeting the histone orthography of cancer: drugs for writers, erasers and readers.

Br J Pharmacol 2015 Jun 5;172(11):2716-32. Epub 2014 Sep 5.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bph.12844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439870PMC
June 2015

Cancer genomics identifies disrupted epigenetic genes.

Hum Genet 2014 Jun 9;133(6):713-25. Epub 2013 Oct 9.

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), 3rd Floor, Hospital Duran i Reynals, Av. Gran Vía 199-203, L'Hospitalet, 08907, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00439-013-1373-5DOI Listing
June 2014

Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient.

Epigenetics 2012 Jun 1;7(6):542-50. Epub 2012 Jun 1.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat; Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/epi.20523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398983PMC
June 2012

DNMT3B gene amplification predicts resistance to DNA demethylating drugs.

Genes Chromosomes Cancer 2011 Jul 11;50(7):527-34. Epub 2011 Apr 11.

Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.20877DOI Listing
July 2011